申请人:WAVE LIFE SCIENCES LTD.
公开号:US10590413B2
公开(公告)日:2020-03-17
The present invention relates to chirally controlled oligonucleotides, chirally controlled oligonucleotide compositions, and the method of making and using the same. The invention specifically encompasses the identification of the source of certain problems with prior methodologies for preparing chiral oligonucleotides, including problems that prohibit preparation of fully chirally controlled compositions, particularly compositions comprising a plurality of oligonucleotide types. In some embodiments, the present invention provides chirally controlled oligonucleotide compositions. In some embodiments, the present invention provides methods of making chirally controlled oligonucleotides and chirally controlled oligonucleotide compositions.
本发明涉及手性受控寡核苷酸、手性受控寡核苷酸组合物以及制作和使用方法。本发明具体包括确定先前制备手性寡核苷酸方法中某些问题的根源,包括禁止制备完全手性控制的组合物,特别是包含多种寡核苷酸类型的组合物的问题。在某些实施方案中,本发明提供了手性控制的寡核苷酸组合物。在一些实施方案中,本发明提供了制作手性控制寡核苷酸和手性控制寡核苷酸组合物的方法。